IL33 and allergic disease: As an initiator, director, and maintainer of allergic inflammation, ATP triggers the release of IL-33 and activates dendritic cells to programme allergic responses [128,129], while in established allergy it augments IgE-dependent mediator release from mast cells and provokes dyspnoea [130,131].